Table 3.

Bivariate random-effects model comparing skin integrity measures throughout the entire study period by gestational age group, Sarlahi, Nepal

Skin Barrier Integrity Measure	Gestational Age1
	34–36 Weeks		≥37 Weeks
	β	95%CI2	β	95%CI
	Erythema, Chest	0.03	−0.09–0.15	−0.01	−0.11–0.12
Erythema, Arm	0.04	−0.09–0.17	0.04	−0.08–0.16
Erythema, Leg	0.03	−0.10–0.16	−0.002	−0.13–0.12
Rash, Chest	0.03	−0.10–0.16	0.07	−0.06–0.19
Rash, Arm	0.05	−0.10–0.19	0.11	−0.02–0.25
Rash, Leg	−0.02	−0.14–0.11	0.05	−0.07–0.17
Dryness, Chest	−0.03	−0.05–0.004	−0.01	−0.04–0.01
Dryness, Arm	−0.02	−0.09–0.05	−0.01	−0.07–0.06
Dryness, Leg	0.01	−0.04–0.06	0.02	−0.03–0.06
Skin pH	−0.19	−0.32–−0.06	−0.08	−0.20–0.04
TEWL3 (g/m2/hr)	2.13	−3.39–7.66	2.63	−3.10–7.22
Protein concentration (μg/cm2)	−1.33	−2.60–−0.06	−0.89	−2.07–0.30

¹Reference Group: Gestational age <34 weeks;

²Confidence Interval;

³Transepidermal water loss